Skip to content
Magazine
Friday, August 1, 2025
SUBSCRIBE
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
  • About Us
  • Belgium News
    • Belgium Police News
    • Brussels News
  • EU Institutions News
    • European Commission News
    • European Parliament News
    • European Council News
  • Europe News
  • World News
  • Belgium Business News
  • Culture and Society News
  • In Depth
    • Ambassador’s Corner
    • The American Angle
    • Sustainable Perspective
    • Europe With Transparency
    • Place de la Bourse
    • The Macro-Economist
    • Southeast Europe
SUBSCRIBE

German Health Minister urges EMA to speed up vaccine approval

Shiva Singh by Shiva Singh
15 December 2020
in Europe News

Brussels (Brussels Morning) Germany’s Minister of Health Jens Spahn is calling on the EU Medicines Agency (EMA) to approve a coronavirus vaccine as soon as possible in order to help put an end to the suffering and uncertainty the pandemic is causing throughout the EU, AP reported yesterday, Monday.

Meanwhile, EMA Executive Director Emer Cooke is stressing the importance of “a thorough evaluation of the benefits and the risks of the vaccine,” noting that EU citizens want to be confident the vaccine is safe and effective.

Cooke says the EMA is working as fast as it can and predicts it could approve the first coronavirus vaccine by 29 December, adding that the date is constantly under review. “European citizens have told us they want a fast approval, but more importantly they want a thorough evaluation of the benefits and the risks of the vaccine,” he insists. 

Germany’s Chancellor Angela Merkel and heads of German states agreed at the weekend to impose new restrictions as of tomorrow, Wednesday, as they step up efforts to control the spread of coronavirus. The stricter measures will remain in effect until 10 January. In recent weeks, epidemiological trends took a decided turn for the worse in Germany, leading Merkel to observe that the restrictions imposed in November had failed to yield expected results.

Reason for Spahn’s impatience

Health Minister Spahn points out that Germany has set up more than 400 vaccination centres, with some 10,000 medical staff now waiting to start mass vaccinations. The situation will affect the trust of EU citizens in the bloc’s capacity to act, he warned, concluding that  “every day that we can start sooner with the vaccinations lessens the suffering and protects those who are the most vulnerable.”

The Ministry of Health pointed out it was ready to administer between three and four million BioNTech vaccines in January and up to 11 million in the first three months of 2021.

The vaccine developed by US Pfizer and German BioNTech has been approved in Canada, the UK, the US and other countries, but cannot be used as yet in the EU, pending approval by the EMA. 

Germany’s President Frank-Walter Steinmeier has called on the citizens to adhere to the latest measures, stressing the severity of the situation. Peter Altmaier, Minister for Economic Affairs and Energy, said that his wish is that for the time being “people will only buy what they really need, like groceries.”

Related News:

  • EU Medicines Agency to speed up coronavirus vaccine approval
  • EMA approves Pfizer/BioNTech vaccine
  • Parliament voices concerns to EMA, ECDC, WHO about vaccine efficacy
  • Croatian MEP claims EMA confirmed his vaccine hesitancy
Tags: Coronavirus vaccineNews
Next Post
Tape on the floor of a McDonald's restaurant, so that customers practice social distancing, during the Coronavirus (covid-19) crisis.

Joint medical editorial criticises UK relaxing COVID rules for Christmas

Latest post

EU-elections-UK

EU elections: UK looks on from the “outside”

1 year ago
Galeries-Royales-Saint-Hubert

What Makes Galeries Royales Saint-Hubert an “Institution”?

1 year ago

Most Read

    Follow Brussels Morning
    Facebook Twitter Youtube Linkedin

    Browse Important News

    Belgium News
    Brussels News
    Culture and Society News
    Economy News
    EU Institutions News
    European Commission News
    European Council News
    European Parliament News
    Europe News
    Health And Fitness News
    Southeast Europe News
    Sustainable Perspective
    World News
    Diplomacy News
    US Elections News

    About Us

    Brussels Morning is a daily online newspaper based in Belgium. BM publishes unique and independent coverage on international and European affairs. With a Europe-wide perspective, BM covers policies and politics of the EU, significant Member State developments, and looks at the international agenda with a European perspective.

    More Info

    • About Us
    • Advertise With Us
    • Contact Us
    • Cookies Policy

    Join Our Newsletter

    Brussels Morning Newspaper – All Rights Reserved © 2024

    No Result
    View All Result
    • Home
    • About Us
    • Belgium News
      • Belgium Police News
      • Brussels News
    • Brussels Bubble
      • European Parliament News
      • European Commission News
      • European Council News
    • Wider Europe
      • Member States
    • World News
    • Business & Society
    • Europe With Transparency
    • Culture & Society
    • Policy Talks
      • Place de la Bourse
      • The Macro-Economist
      • Sustainable Perspective
      • Ambassador’s Corner
      • The American Angle
      • Southeast Europe
    • Print Magazine

    Brussels Morning Newspaper - All Rights Reserved © 2020

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
    Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT